Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The joint capsule is an envelope of dense fibrous connective tissue that surrounds a synovial joint, consisting of two layers: an outer fibrous membrane and an inner synovial membrane. It seals the joint space, provides passive and active stability, limits excessive movements, and is attached to bones via specialized attachment zones. The capsule varies in thickness depending on local mechanical stress and may incorporate ligaments and tendons. It is clinically significant in diseases such as rheumatoid arthritis, osteoarthritis, crystal deposition disorders, ankylosing spondylitis, as well as injuries and conditions like frozen shoulder and plica syndrome. The joint capsule is not a molecular therapeutic target but rather a macro-anatomical structure made of collagen-rich connective tissue, responding to injury and disease primarily through structural and pathological adaptations.
None (no mechanism of action as a molecular target; tissue manipulation sometimes involves surgery or corticosteroid injection for inflammation)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Joint capsule.